Literature DB >> 22247539

At issue: Cochrane, early intervention, and mental health reform: analysis, paralysis, or evidence-informed progress?

Patrick McGorry1.   

Abstract

Among the noncommunicable diseases, mental ill-health represents the major threat to social and economic progress because it impacts so powerfully on the most critical decades of life. Consequently, mental health reform is increasingly recognized as an urgent priority worldwide. This brings into sharp focus the role of evidence, and more specifically the Cochrane paradigm, in influencing decisions about health system reform. Cochrane clearly still has great value, especially in evidence-based medicine, where the focus is the evaluation of individual treatments. However, it cannot be allowed to be a dominant influence in evidence-based health care (EBHC) policy decisions for health system reform, unless it is modernized or complemented. Health services reform should definitely be as evidence-based as possible; however, the jury should consider its verdict on key reform proposals based on the balance of probabilities and informed by the best "available" evidence from all sources, not only randomized clinical trials, which in many domains may be never be feasible. This is particularly the case when reform is urgent, and the status quo has manifestly failed. So on the one hand, the evidence-based paradigm must not be misused to stifle or paralyze urgent reform. Alternatively, there is a real risk that, if we do not improve the sophistication of EBHC, the whole paradigm will be sidelined and reform will remain reactive, impulsive, and desultory. The recent Cochrane review on early intervention in psychosis provides an opportunity to consider these issues and their wider significance.

Entities:  

Mesh:

Year:  2012        PMID: 22247539      PMCID: PMC3283140          DOI: 10.1093/schbul/sbr185

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  20 in total

1.  Defeating the merchants of doubt.

Authors:  Naomi Oreskes; Erik M Conway
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

2.  Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness.

Authors:  Antonio Preti; Matteo Cella
Journal:  Schizophr Res       Date:  2010-08-21       Impact factor: 4.939

Review 3.  Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions.

Authors:  Patrick D McGorry; Ian B Hickie; Alison R Yung; Christos Pantelis; Henry J Jackson
Journal:  Aust N Z J Psychiatry       Date:  2006-08       Impact factor: 5.744

4.  Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study.

Authors:  R W Grawe; I R H Falloon; J H Widen; E Skogvoll
Journal:  Acta Psychiatr Scand       Date:  2006-11       Impact factor: 6.392

5.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

Review 6.  EPPIC: an evolving system of early detection and optimal management.

Authors:  P D McGorry; J Edwards; C Mihalopoulos; S M Harrigan; H J Jackson
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

7.  Integrated treatment of first-episode psychosis: effect of treatment on family burden: OPUS trial.

Authors:  Pia Jeppesen; Lone Petersen; Anne Thorup; Maj-Britt Abel; Johan Oehlenschlaeger; Torben Ø Christensen; Gertrud Krarup; Ralf Hemmingsen; Per Jørgensen; Merete Nordentoft
Journal:  Br J Psychiatry Suppl       Date:  2005-08

8.  Effect of an early detection programme on duration of untreated psychosis: part of the Scandinavian TIPS study.

Authors:  Svein Friis; Per Vaglum; Ulrik Haahr; Jan Olav Johannessen; Tor K Larsen; Ingrid Melle; Stein Opjordsmoen; Bjørn Risovd Rund; Erik Simonsen; Thomas H McGlashan
Journal:  Br J Psychiatry Suppl       Date:  2005-08

9.  Improving 1-year outcome in first-episode psychosis: OPUS trial.

Authors:  Lone Petersen; Merete Nordentoft; Pia Jeppesen; Johan Ohlenschaeger; Anne Thorup; Torben Østergaard Christensen; Gertrud Krarup; Jytte Dahlstrøm; Bodil Haastrup; Per Jørgensen
Journal:  Br J Psychiatry Suppl       Date:  2005-08

10.  Integrated treatment ameliorates negative symptoms in first episode psychosis--results from the Danish OPUS trial.

Authors:  A Thorup; L Petersen; P Jeppesen; J Ohlenschlaeger; T Christensen; G Krarup; P Jørgensen; M Nordentoft
Journal:  Schizophr Res       Date:  2005-11-01       Impact factor: 4.939

View more
  3 in total

1.  Not at issue.

Authors:  Clive E Adams
Journal:  Schizophr Bull       Date:  2012-01-18       Impact factor: 9.306

2.  First-Episode Services for Psychotic Disorders in the U.S. Public Sector: A Pragmatic Randomized Controlled Trial.

Authors:  Vinod H Srihari; Cenk Tek; Suat Kucukgoncu; Vivek H Phutane; Nicholas J K Breitborde; Jessica Pollard; Banu Ozkan; John Saksa; Barbara C Walsh; Scott W Woods
Journal:  Psychiatr Serv       Date:  2015-02-02       Impact factor: 3.084

3.  Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative.

Authors:  Lisa B Dixon; Howard H Goldman; Vinod H Srihari; John M Kane
Journal:  Annu Rev Clin Psychol       Date:  2018-01-12       Impact factor: 18.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.